SRE Holdings (2980) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Sep, 2025Executive summary
Net sales rose 18.1% year-over-year to ¥5,067 million for the quarter ended June 30, 2024.
Operating profit surged 320.6% year-over-year to ¥851 million, with ordinary profit up 387.8% to ¥815 million.
Profit attributable to owners of parent increased 271.4% year-over-year to ¥497 million.
Comprehensive income reached ¥535 million, up 282.2% year-over-year.
Financial highlights
Gross profit increased to ¥2,450 million from ¥1,414 million year-over-year.
Basic quarterly profit per share was ¥30.92, up from ¥8.28 year-over-year.
Total assets grew to ¥31,105 million from ¥24,017 million at the previous fiscal year-end.
Equity ratio decreased to 39.6% from 50.6% at the previous fiscal year-end.
Outlook and guidance
Full-year net sales forecast at ¥27,000 million, up 11.5% year-over-year.
Operating profit forecast at ¥3,050 million, up 37.9% year-over-year.
Profit attributable to owners of parent projected at ¥1,850 million, up 33.2% year-over-year.
No dividend is planned for the fiscal year.
Latest events from SRE Holdings
- Record profit and revenue growth driven by AI and real estate, with strong outlook.2980
Q3 202610 Feb 2026 - Profits fell sharply, but AI and healthcare segments grew; strong 2H recovery expected.2980
Q2 202611 Nov 2025 - Sales declined and a net loss was posted, but AI Cloud & Consulting showed strong growth.2980
Q1 20268 Sep 2025 - Double-digit sales and profit growth, boosted by Medix acquisition and segment expansion.2980
Q2 20258 Sep 2025 - Sales up 12.6% but profit down 31.7%; Medix acquisition drives asset and goodwill growth.2980
Q3 20258 Sep 2025 - Strong revenue and profit growth with FY2026 guidance projecting over 30% increases.2980
Q4 20258 Sep 2025